Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Diagnostic Nuclear Medicines market report explains the definition, types, applications, major countries, and major players of the Diagnostic Nuclear Medicines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
China Isotope & Radiation
Bayer
Bracco Imaging
Triad Isotopes
Novartis
Nordion
GE Healthcare
Dongcheng
Lantheus
Navidea
Eli Lilly
Jubilant Pharma
SIEMENS
Curium Pharmaceuticals
By Type:
Tc-99m
F-18
Other
By End-User:
Oncology
Cardiology
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Diagnostic Nuclear Medicines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Diagnostic Nuclear Medicines Outlook to 2028- Original Forecasts
-
2.2 Diagnostic Nuclear Medicines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Diagnostic Nuclear Medicines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Diagnostic Nuclear Medicines Market- Recent Developments
-
6.1 Diagnostic Nuclear Medicines Market News and Developments
-
6.2 Diagnostic Nuclear Medicines Market Deals Landscape
7 Diagnostic Nuclear Medicines Raw Materials and Cost Structure Analysis
-
7.1 Diagnostic Nuclear Medicines Key Raw Materials
-
7.2 Diagnostic Nuclear Medicines Price Trend of Key Raw Materials
-
7.3 Diagnostic Nuclear Medicines Key Suppliers of Raw Materials
-
7.4 Diagnostic Nuclear Medicines Market Concentration Rate of Raw Materials
-
7.5 Diagnostic Nuclear Medicines Cost Structure Analysis
-
7.5.1 Diagnostic Nuclear Medicines Raw Materials Analysis
-
7.5.2 Diagnostic Nuclear Medicines Labor Cost Analysis
-
7.5.3 Diagnostic Nuclear Medicines Manufacturing Expenses Analysis
8 Global Diagnostic Nuclear Medicines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Diagnostic Nuclear Medicines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Diagnostic Nuclear Medicines Export by Region (Top 10 Countries) (2017-2028)
9 Global Diagnostic Nuclear Medicines Market Outlook by Types and Applications to 2022
-
9.1 Global Diagnostic Nuclear Medicines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tc-99m Consumption and Growth Rate (2017-2022)
-
9.1.2 Global F-18 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Diagnostic Nuclear Medicines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Diagnostic Nuclear Medicines Market Analysis and Outlook till 2022
-
10.1 Global Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.2.2 Canada Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.2.3 Mexico Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.2 UK Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.3 Spain Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.4 Belgium Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.5 France Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.6 Italy Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.7 Denmark Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.8 Finland Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.9 Norway Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.10 Sweden Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.11 Poland Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.12 Russia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.3.13 Turkey Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.2 Japan Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.3 India Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.4 South Korea Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.5 Pakistan Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.6 Bangladesh Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.7 Indonesia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.8 Thailand Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.9 Singapore Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.10 Malaysia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.11 Philippines Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.4.12 Vietnam Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.2 Colombia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.3 Chile Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.4 Argentina Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.5 Venezuela Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.6 Peru Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.7 Puerto Rico Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.5.8 Ecuador Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6.2 Kuwait Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6.3 Oman Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6.4 Qatar Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.7.2 South Africa Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.7.3 Egypt Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.7.4 Algeria Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Diagnostic Nuclear Medicines Consumption (2017-2022)
-
10.8.2 New Zealand Diagnostic Nuclear Medicines Consumption (2017-2022)
11 Global Diagnostic Nuclear Medicines Competitive Analysis
-
11.1 China Isotope & Radiation
-
11.1.1 China Isotope & Radiation Company Details
-
11.1.2 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 China Isotope & Radiation Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.1.4 China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Bayer
-
11.2.1 Bayer Company Details
-
11.2.2 Bayer Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Bayer Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.2.4 Bayer Diagnostic Nuclear Medicines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Bracco Imaging
-
11.3.1 Bracco Imaging Company Details
-
11.3.2 Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Bracco Imaging Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.3.4 Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Triad Isotopes
-
11.4.1 Triad Isotopes Company Details
-
11.4.2 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Triad Isotopes Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.4.4 Triad Isotopes Diagnostic Nuclear Medicines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.5.4 Novartis Diagnostic Nuclear Medicines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Nordion
-
11.6.1 Nordion Company Details
-
11.6.2 Nordion Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Nordion Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.6.4 Nordion Diagnostic Nuclear Medicines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 GE Healthcare
-
11.7.1 GE Healthcare Company Details
-
11.7.2 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 GE Healthcare Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.7.4 GE Healthcare Diagnostic Nuclear Medicines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Dongcheng
-
11.8.1 Dongcheng Company Details
-
11.8.2 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Dongcheng Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.8.4 Dongcheng Diagnostic Nuclear Medicines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Lantheus
-
11.9.1 Lantheus Company Details
-
11.9.2 Lantheus Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Lantheus Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.9.4 Lantheus Diagnostic Nuclear Medicines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Navidea
-
11.10.1 Navidea Company Details
-
11.10.2 Navidea Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Navidea Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.10.4 Navidea Diagnostic Nuclear Medicines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Eli Lilly
-
11.11.1 Eli Lilly Company Details
-
11.11.2 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Eli Lilly Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.11.4 Eli Lilly Diagnostic Nuclear Medicines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Jubilant Pharma
-
11.12.1 Jubilant Pharma Company Details
-
11.12.2 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Jubilant Pharma Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.12.4 Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 SIEMENS
-
11.13.1 SIEMENS Company Details
-
11.13.2 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 SIEMENS Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.13.4 SIEMENS Diagnostic Nuclear Medicines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Curium Pharmaceuticals
-
11.14.1 Curium Pharmaceuticals Company Details
-
11.14.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Main Business and Markets Served
-
11.14.4 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Diagnostic Nuclear Medicines Market Outlook by Types and Applications to 2028
-
12.1 Global Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Diagnostic Nuclear Medicines Market Analysis and Outlook to 2028
-
13.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2.2 Canada Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.2 UK Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.3 Spain Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.5 France Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.6 Italy Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.8 Finland Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.9 Norway Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.11 Poland Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.12 Russia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.2 Japan Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.3 India Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.3 Chile Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.6 Peru Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.3 Oman Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Diagnostic Nuclear Medicines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Diagnostic Nuclear Medicines
-
Figure of Diagnostic Nuclear Medicines Picture
-
Table Global Diagnostic Nuclear Medicines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Diagnostic Nuclear Medicines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Tc-99m Consumption and Growth Rate (2017-2022)
-
Figure Global F-18 Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Table North America Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure United States Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Canada Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Europe Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Germany Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure UK Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Spain Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure France Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Italy Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Finland Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Norway Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Poland Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Russia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table APAC Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure China Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Japan Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure India Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table South America Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Brazil Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Chile Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Peru Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table GCC Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Bahrain Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Oman Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Africa Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Nigeria Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table Oceania Diagnostic Nuclear Medicines Consumption by Country (2017-2022)
-
Figure Australia Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Diagnostic Nuclear Medicines Consumption and Growth Rate (2017-2022)
-
Table China Isotope & Radiation Company Details
-
Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Isotope & Radiation Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table China Isotope & Radiation Diagnostic Nuclear Medicines Product Portfolio
-
Table Bayer Company Details
-
Table Bayer Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Bayer Diagnostic Nuclear Medicines Product Portfolio
-
Table Bracco Imaging Company Details
-
Table Bracco Imaging Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bracco Imaging Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Bracco Imaging Diagnostic Nuclear Medicines Product Portfolio
-
Table Triad Isotopes Company Details
-
Table Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Triad Isotopes Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Triad Isotopes Diagnostic Nuclear Medicines Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Novartis Diagnostic Nuclear Medicines Product Portfolio
-
Table Nordion Company Details
-
Table Nordion Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nordion Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Nordion Diagnostic Nuclear Medicines Product Portfolio
-
Table GE Healthcare Company Details
-
Table GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table GE Healthcare Diagnostic Nuclear Medicines Product Portfolio
-
Table Dongcheng Company Details
-
Table Dongcheng Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dongcheng Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Dongcheng Diagnostic Nuclear Medicines Product Portfolio
-
Table Lantheus Company Details
-
Table Lantheus Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lantheus Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Lantheus Diagnostic Nuclear Medicines Product Portfolio
-
Table Navidea Company Details
-
Table Navidea Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Navidea Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Navidea Diagnostic Nuclear Medicines Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Eli Lilly Diagnostic Nuclear Medicines Product Portfolio
-
Table Jubilant Pharma Company Details
-
Table Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jubilant Pharma Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Jubilant Pharma Diagnostic Nuclear Medicines Product Portfolio
-
Table SIEMENS Company Details
-
Table SIEMENS Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIEMENS Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table SIEMENS Diagnostic Nuclear Medicines Product Portfolio
-
Table Curium Pharmaceuticals Company Details
-
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Main Business and Markets Served
-
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Portfolio
-
Figure Global Tc-99m Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global F-18 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Table North America Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure United States Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Germany Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure China Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Diagnostic Nuclear Medicines Consumption Forecast by Country (2022-2028)
-
Figure Australia Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Diagnostic Nuclear Medicines Consumption Forecast and Growth Rate (2022-2028)
-
